Authors: Yang, XD Jia, XC Corvalan, JRF Wang, P Davis, CG

Citation: Xd. Yang et al., Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy, CR R ONC H, 38(1), 2001, pp. 17-23

Authors: Russell, ND Corvalan, JRF Gallo, ML Davis, CG Pirofski, LA

Citation: Nd. Russell et al., Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci, INFEC IMMUN, 68(4), 2000, pp. 1820-1826

Authors: Yang, XD Corvalan, JRF Wang, P Roy, CMN Davis, CG

Citation: Xd. Yang et al., Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states, J LEUK BIOL, 66(3), 1999, pp. 401-410

Authors: Davis, CG Gallo, ML Corvalan, JRF

Citation: Cg. Davis et al., Transgenic mice as a source of fully human antibodies for the treatment ofcancer, CANC METAST, 18(4), 1999, pp. 421-425

Authors: Yang, XD Jia, XC Corvalan, JRF Wang, P Davis, CG Jakobovits, A

Citation: Xd. Yang et al., Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy, CANCER RES, 59(6), 1999, pp. 1236-1243